BL Pharmtech Corp.

KOSDAQ:A065170 株式レポート

時価総額：₩38.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

BL Pharmtech マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Hyo-Lim Lee

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Sep 03
BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

May 21
Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Mar 07
Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Mar 14
Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Jan 20
Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

Nov 28
Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

CEO（最高経営責任者

Hyo-Lim Lee

no data

在職期間

Mr. Hyo-Lim Lee serves as the Chief Executive Officer of BL Pharmtech Corp. (formerly known as NRD Co., Ltd.).